NCT01542489 - Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos | Biotech Hunter

Enrollment

480

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Prescribed by the physician solely as a result of a normal clinical evaluation. The physician determines the starting dose and frequency, as well as later changes to either dose or frequency, if any

DRUG

insulin aspart

Prescribed by the physician solely as a result of a normal clinical evaluation. The physician determines the starting dose and frequency, as well as later changes to either dose or frequency, if any

DRUG

human soluble insulin

Prescribed by the physician solely as a result of a normal clinical evaluation. The physician determines the starting dose and frequency, as well as later changes to either dose or frequency, if any

Trial Locations (1)

811 05

Novo Nordisk Investigational Site, Bratislava